Transarterial chemoembolization combined donafenib with/without PD-1 for unresectable HCC in a multicenter retrospective study

Background & aimsThis multicenter retrospective study evaluated the efficacy and safety of transarterial chemoembolization (TACE) combined with donafenib and a programmed death-1 (PD-1) inhibitor (TACE+DP) and TACE combined with donafenib (TACE+D) for unresectable hepatocellular carcinoma (uHCC)...

Повний опис

Бібліографічні деталі

Автори:	Hao Li, Jiacheng Wang, Guokun Zhang, Donglin Kuang, Yanliang Li, Xiang He, Cheng Xing, Yong Wang, Ming Shi, Xinwei Han, Jianzhuang Ren, Xuhua Duan
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2023-11-01
Серія:	Frontiers in Immunology
Предмети:	donafenib programmed death-1 inhibitors transarterial chemoembolization unresectable hepatocellular carcinoma multicenter retrospective study
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1277329/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!